Extensions

US Patent 9,549,918: Term, Continuations, and Family

Projected Expiration Date

The projected expiration date for US patent 9,549,918 is May 30, 2028. This date is calculated 20 years from the earliest effective non-provisional filing date, which is May 30, 2008. This date stems from the patent's claim to priority from International Application No. PCT/DK08/050130, which was filed on that day.

Patent Term Adjustments (PTA) and Extensions (PTE)

• Patent Term Adjustment (PTA): The front page of the issued patent explicitly states that the term of the patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. PTA is granted to compensate for certain administrative delays by the U.S. Patent and Trademark Office (USPTO) during prosecution. In this case, no such adjustment was awarded.

• Patent Term Extension (PTE): There is no evidence that a Patent Term Extension under 35 U.S.C. § 156 was sought or granted for this patent. PTE is used to restore patent life lost during a product's regulatory review period by agencies like the FDA.

Continuation and Divisional Applications

The patent is part of a larger family of applications that includes several continuations, which are applications that claim the benefit of the filing date of an earlier application.

• Parent Application: US patent 9,549,918 issued from application US13/029,304, which is a continuation-in-part of application US12/499,034 (filed July 7, 2009, and now issued as US Patent 8,685,998).

• Continuation (Child) Applications: Several applications have been filed that claim continuation status from the '918 patent or its parent, extending the patent family:

  • US15/405,879: Filed January 13, 2017, and issued as US 10,166,190 B2.
  • US16/188,805: Filed November 13, 2018, and issued as US 11,419,823 B2.
  • US17/857,442: Filed July 5, 2022, and issued as US 12,403,095 B2.

• Divisional Applications: Based on the provided documentation, there are no applications identified as divisional applications related to US 9,549,918.

Patent Family Members

US patent 9,549,918 is part of an extensive international patent family. Key family members include:

• United States:

  • US 8,685,998 B2 (Parent)
  • US 10,166,190 B2 (Continuation)
  • US 11,419,823 B2 (Continuation)
  • US 12,403,095 B2 (Continuation)

• International:

  • WO 2011/100975 A2: The international application filed under the Patent Cooperation Treaty (PCT).
  • EP 2575769 B1: The patent granted by the European Patent Office.
  • Counterpart patents and applications have also been filed in Argentina (AR), Taiwan (TW), and several other jurisdictions, including under the Eurasian Patent Organization (EA).